MTHERA PHARMA
Latest round
- Series A
Last raised
- Apr 2021
Total raised
- $2.8M
Investors
- 3
About MTHERA PHARMA
Based in Seoul, South Korea, and founded in 2020 by co-founders Kim Sang-geon, Kim Sun-yeo, Lee Chung-hwan, Oh Myung-sook, and Jang Young-pyo, MTHERA PHARMA specializes in the research, development, and commercialization of pharmaceutical products. The company boasts a diverse pipeline of promising therapies targeting various therapeutic areas, including oncology, neurology, cardiovascular diseases, and rare disorders. As of 2023, the company's CEO is Min Won Shon. The company offers natural drug products to treat chronic incurable diseases, such as parkinson’s disease, inflammatory bowel diseases, type 2 diabetes mellitus, and alzheimer’s diseases. MTHERA PHARMA uses the multicomponent multi-target (MCMT) approach to solve the limitations of single-target treatment for chronic incurable diseases. The platform uses an artificial intelligence (AI)-based big data system and a multi-omics analysis system that analyses virtual human body systems on a clinical basis. In addition, the firm's pipeline products include MT101 (Parkinson’s treatment, phase 3 clinical trial), MT102 (inflammatory bowel diseases), MT103 (Diabetic neuropathy treatment, phase 2), MT104 (alzheimer’s diseases), MT106 (Anti-Viral), and GCWB204 (cancer, phase 2).
Who invested in MTHERA PHARMA
3 investors across 1 round
See all investors in MTHERA PHARMA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 9, 2021
Amount
$2.8M
Investors
Questions about MTHERA PHARMA
Who invested in MTHERA PHARMA?
MTHERA PHARMA has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MTHERA PHARMA raised?
MTHERA PHARMA has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MTHERA PHARMA last raise money?
MTHERA PHARMA's most recent round on record is a Series A, in Apr 2021.
What does MTHERA PHARMA do?
Based in Seoul, South Korea, and founded in 2020 by co-founders Kim Sang-geon, Kim Sun-yeo, Lee Chung-hwan, Oh Myung-sook, and Jang Young-pyo, MTHERA PHARMA specializes in the research, development, and commercialization of pharmaceutical products.
Where is MTHERA PHARMA headquartered?
MTHERA PHARMA is headquartered in Seoul, South Korea.
Which VCs invest in companies like MTHERA PHARMA?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MTHERA PHARMA's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like MTHERA PHARMA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.